ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ASND Ascendis Pharma AS

136.93
-6.25 (-4.37%)
26 Apr 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 375,167
Bid Price 110.66
Ask Price 185.00
News (1)
Share Name Share Symbol Market Stock Type
Ascendis Pharma AS ASND NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-6.25 -4.37% 136.93 10:00:00
Open Price Low Price High Price Close Price Previous Close
140.84 136.19 140.84 136.93 143.18
Trades Shares Traded VWAP Financial Volume Average Volume
7,380 375,167  137.99  51,767,756 -
Last Trade Type Quantity Price Currency
07:31:54 priorref 10,100  136.93 USD

Ascendis Pharma AS (ASND) Options Flow Summary

Overall Flow

Bearish

Net Premium

-2M

Calls / Puts

100.00%

Buys / Sells

150.00%

OTM / ITM

220.00%

Sweeps Ratio

0.00%

Ascendis Pharma AS Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 0.00 - 200.64M -481.45M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Ascendis Pharma AS

Date Time Source Heading
26/4/202406:46GlobeNewswire Inc.Ascendis Pharma to Report First Quarter 2024 Financial..
24/4/202422:30GlobeNewswire Inc.United Kingdom’s MHRA Approves YORVIPATH®..
08/3/202403:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
06/3/202413:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
06/3/202400:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
06/3/202400:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/3/202423:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/3/202407:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/3/202407:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/3/202406:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/3/202406:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/3/202400:30GlobeNewswire Inc.Ascendis Pharma to Participate in the Leerink Partners..

ASND Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Your Recent History

Delayed Upgrade Clock